Amneal Pharmaceuticals Inc (AMRX)
6.815
+0.06
(+0.96%)
USD |
NASDAQ |
May 17, 16:00
6.815
0.00 (0.00%)
Pre-Market: 20:00
Amneal Pharmaceuticals Total Assets (Quarterly): 3.456B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.456B |
December 31, 2023 | 3.473B |
September 30, 2023 | 3.687B |
June 30, 2023 | 3.701B |
March 31, 2023 | 3.627B |
December 31, 2022 | 3.799B |
September 30, 2022 | 3.874B |
June 30, 2022 | 4.041B |
March 31, 2022 | 3.889B |
December 31, 2021 | 3.940B |
September 30, 2021 | 3.974B |
June 30, 2021 | 4.023B |
March 31, 2021 | 3.960B |
Date | Value |
---|---|
December 31, 2020 | 4.006B |
September 30, 2020 | 4.038B |
June 30, 2020 | 4.057B |
March 31, 2020 | 4.391B |
December 31, 2019 | 3.666B |
September 30, 2019 | 3.704B |
June 30, 2019 | 4.262B |
March 31, 2019 | 4.385B |
December 31, 2018 | 4.353B |
September 30, 2018 | 4.582B |
June 30, 2018 | 4.545B |
December 31, 2017 | 1.342B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.456B
Minimum
Mar 2024
4.391B
Maximum
Mar 2020
3.878B
Average
3.914B
Median
Total Assets (Quarterly) Benchmarks
Fate Therapeutics Inc | 569.89M |
Ocular Therapeutix Inc | 538.95M |
Editas Medicine Inc | 440.35M |
AnaptysBio Inc | 405.84M |
AEON Biopharma Inc | -- |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.473B |
Shareholders Equity (Quarterly) | -63.72M |
Debt to Equity Ratio | -41.31 |
Current Ratio | 1.654 |
Net Debt Paydown Yield | 0.96% |